Press Releases
FDA Approves Roche’s ENSPRYNG for Neuromyelitis Optica Spectrum Disorder
Roche announced that the US FDA has approved ENSPRYNGâ„¢ (satralizumab-mwge) as the first and only subcutaneous treatment for adults living with anti-aquaporin-4 (AQP4) antibody...
Clinical Trials
Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced the beginning of a Phase 2b clinical trial in South...
News
Sanofi to acquire Principia Biopharma
Sanofi and Principia Biopharma Inc., a late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases, entered into a definitive agreement under which Sanofi...
News
Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Hengrui Therapeutics, Inc.
Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Hengrui Therapeutics, Inc. (HTI), a U.S. subsidiary of Chinese pharmaceutical company Jiangsu Hengrui...
Drug Research
Memo Therapeutics and Northway Biotech collaborate on the fast-track manufacturing of a SARS-CoV-2-neutralizing antibody for the therapy of COVID-19
Swiss biotech company Memo Therapeutics AG (MTx), and Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announce a new partnership...
Press Releases
TFF Pharmaceuticals Enters into Worldwide Licensing Agreement with UNION therapeutics for its Thin Film Freezing Technology in Combination with niclosamide
TFF Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology...
Press Releases
Biological E. Limited Acquires Akorn India
Biological E. Limited, a Hyderabad-based pharmaceuticals & Biologics company, announced the acquisition of Akorn India Limited, a subsidiary of Akorn Inc., USA.
By this strategic...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read